Breast Cancer Recurrent Clinical Trials

19 clinical trials for Breast Cancer Recurrent across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) — RECRUITING · NA
• First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer — RECRUITING · PHASE1
• Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC — RECRUITING · PHASE2
• Thermotherapy in Addition to SOC Palliative Radiotherapy — RECRUITING · NA
• 18F-FDG PET/CT Imaging for Breast Cancer — RECRUITING · NA
• aPBI Re-irradiation — NOT_YET_RECRUITING · PHASE1
• Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers — TERMINATED · PHASE1
• GISEL:Registry of Breast Cancer Patients Treated With ECT — COMPLETED
• Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer — OTHER · PHASE2
• EpCAM CAR-T for Treatment of Advanced Solid Tumors — OTHER · PHASE1
• Registry of Local Recurrences After Breast-conserving Surgery — NOT_YET_RECRUITING
• Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients — COMPLETED · PHASE3
• Prolonged Nightly Fasting in Breast Cancer Survivors — COMPLETED · NA
• Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients. — COMPLETED · PHASE1
• Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer — COMPLETED · PHASE1
• Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab — COMPLETED · PHASE4
• S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer — OTHER · PHASE2
• Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT — COMPLETED · NA

Refine this search